January 24, 2022
Is Omicron Our Way Out?
As 2022 begins, the pandemic is still at the forefront of the healthcare industry. Recently, as COVID-19 case counts have risen dramatically around the world due to the highly infectious Omicron variant, new challenges are presenting:
- What is the best mitigation strategy?
- How do we protect the vulnerable?
- How and when should we test?
- Does this mean we are closer to a new "normal"?
Join A&M Healthcare Industry Group's Marthe Haverkamp, M.D., Ph.D, as she sits down with world-renowned virologist Ab Osterhaus, Ph.D., and vaccine expert Manon Cox, Ph.D., MBA, Chief Executive Officer and Co-Founder of NextWaveBio. They discuss the future of vaccines, the value of COVID-19 treatments, and the influence of Omicron on the pandemic: Is a relatively mild disease now a comparative advantage for the future?
Subscribe to our Healthcare Industry Group Podcast:
![]() |
![]() |
![]() |
![]() |